Artem Rubinstein
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Tuberculosis Research and Epidemiology
-
- Long-Term Effects of COVID-19
Papers in
-
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 5
- Tuberculosis Research and Epidemiology 4
-
- Inflammasome and immune disorders 4
- Co-authors
- I. V. Kudryavtsev (18 shared papers)Igor Kudryavtsev (11 shared papers)Dmitry Isakov (5 shared papers)N. A. Аrsentieva (6 shared papers)Арег А. Тотолян (6 shared papers)Olga Kalinina (4 shared papers)А. С. Головкин (9 shared papers)Oksana V. Stanevich (4 shared papers)
- Journals
- Current Issues in Molecular Biology (5 papers)International Journal of Molecular Sciences (4 papers)Frontiers in Medicine (3 papers)Viruses (3 papers)Biomedicines (2 papers)
- Partner nations
- RussiaTajikistanChina
In The Last Decade
Artem Rubinstein
28 papers receiving 228 citations
Peers
Comparison fields: 5 of 60
- Infectious Diseases 91
- Neurology 39
- Pharmaceutical Science 14
- Molecular Medicine 10
- Immunology 40
Countries citing papers authored by Artem Rubinstein
This map shows the geographic impact of Artem Rubinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Artem Rubinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Artem Rubinstein more than expected).
Fields of papers citing papers by Artem Rubinstein
This network shows the impact of papers produced by Artem Rubinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Artem Rubinstein. The network helps show where Artem Rubinstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Artem Rubinstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 29 | |
| 2 | 2022 | 29 | |
| 3 | 2021 | 21 | |
| 4 | 2022 | 19 | |
| 5 | 2022 | 14 | |
| 6 | 2023 | 14 | |
| 7 | 2023 | 13 | |
| 8 | 2022 | 13 | |
| 9 | 2024 | 12 | |
| 10 | 2023 | 11 | |
| 11 | 2023 | 10 | |
| 12 | 2023 | 9 | |
| 13 | 2023 | 6 | |
| 14 | 2024 | 5 | |
| 15 | 2025 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2025 | 3 | |
| 20 | 2024 | 2 |
About Artem Rubinstein
Artem Rubinstein is a scholar working on Infectious Diseases, Molecular Biology, Immunology, Surgery and Neurology, having authored 37 papers that have together received 232 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), Advanced Drug Delivery Systems (5 papers), COVID-19 Clinical Research Studies (5 papers), Tuberculosis Research and Epidemiology (4 papers), Inflammasome and immune disorders (4 papers), Long-Term Effects of COVID-19 (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Infectious Diseases (91 citations), Neurology (39 citations), Pharmaceutical Science (14 citations), Molecular Medicine (10 citations) and Immunology (40 citations). Artem Rubinstein has collaborated with scholars based in Russia, Tajikistan and China. Frequent co-authors include I. V. Kudryavtsev, Igor Kudryavtsev, Dmitry Isakov, N. A. Аrsentieva, Арег А. Тотолян, Olga Kalinina, А. С. Головкин, Oksana V. Stanevich, Irina Isakova–Sivak and Andrey S. Trulioff. Their work appears in journals such as Current Issues in Molecular Biology, International Journal of Molecular Sciences, Frontiers in Medicine, Viruses and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.